From Investorplace: Predicting the short-term moves of any security is tough business, but technical analysis and an assessment of current fundamentals can help. Stocks flashing technical sell … [Read more...]

From Investorplace: This week, 21 Biotechnology stocks are worse, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”). Read more... … [Read more...]

From Street Authority: While some popular names no doubt seem attractive at current beaten-down levels, the Alpha Score can help us separate the potential winners from those likely to remain … [Read more...]

From The Street: From hedge funds to individual investors, scores of market participants are turning to social media to figure out which stocks are worth watching. It's a concept that's known as … [Read more...]

From Investorplace: This week, the ratings of 14 Biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”). Read more... … [Read more...]

From Investorplace: The ratings of 7 Media stocks are down this week, according to thePortfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”). Read more... … [Read more...]

From Motley Fool: With the S&P 500 having dipping into "correction" territory, there are bound to be deals available for the astute investor. However, for every "steal" there are just as many … [Read more...]

From Investorplace: This week, the overall grades of 3 Health Care Technology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall … [Read more...]

From Forbes: In October 2014, Carl Icahn predicted that Apple shares would end 2015 at $200. The year is almost over and Icahn’s prediction is not coming true. Nor does it help that Morgan … [Read more...]